- Home
- CRNC vs DERM Comparison
CRNC vs DERM Comparison
Compare CRNC & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRNC | DERM |
|---|---|---|
| Founded | 2020 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 316.0M | 267.4M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CRNC | DERM |
|---|---|---|
| Price | $7.12 | $6.98 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $11.50 | ★ $12.67 |
| AVG Volume (30 Days) | ★ 654.7K | 103.9K |
| Earning Date | 05-06-2026 | 03-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 96.95 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $251,781,000.00 | $56,134,000.00 |
| Revenue This Year | $27.17 | $17.48 |
| Revenue Next Year | N/A | $55.83 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.94 | $5.48 |
| 52 Week High | $13.74 | $9.56 |
Technical Indicators
Market Signals| Indicator | CRNC | DERM |
|---|---|---|
| Relative Strength Index (RSI) | 34.22 | 33.54 |
| Support Level | $6.41 | $6.77 |
| Resistance Level | $11.87 | $7.92 |
| Average True Range (ATR) | 0.31 | 0.47 |
| MACD | 0.10 | -0.11 |
| Stochastic Oscillator | 26.26 | 4.98 |
Price Performance
Historical ComparisonAbout CRNC Cerence Inc.
Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services. Geographically, it derives a majority of its revenue from the United States and also has a presence in Other Americas; Germany; Other Europe, the Middle East, Africa; Japan, and Other Asia-Pacific.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.